Although a smaller segment within the in vitro diagnostic market, the molecular diagnostics sector is becoming increasingly important for the pharmaceutical market as personalized healthcare takes off.
Features and benefits
Highlights
This report identifies the leading players that are active in MDx, evaluating trends in corporate strategy and discussing the impact of key recent licensing deals.
Table of Contents
EXECUTIVE SUMMARY
Key players
M&A
COMPANY PROFILES
Overview
Roche Molecular Diagnostics
Siemens
Abbott Molecular
Novartis
Becton, Dickinson and Company
Gen-Probe
Qiagen
bioMerieux
Dako
Cepheid
APPENDIX
List of Tables
Complete Table of Contents, Inquire Before Buying and more for the report : Molecular Diagnostics Key Players